Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
33.05 USD | +5.59% | +4.65% | +1.85% |
11:38am | Truist Adjusts Price Target on Corcept Therapeutics to $65 From $44, Maintains Buy Rating | MT |
May. 28 | Sector Update: Health Care Stocks Retreat Tuesday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.85% | 3.26B | |
+42.59% | 748B | |
+34.11% | 598B | |
-6.01% | 356B | |
+18.30% | 325B | |
+4.94% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+3.11% | 166B |
- Stock Market
- Equities
- CORT Stock
- News Corcept Therapeutics Incorporated
- Corcept Therapeutics Insider Sold Shares Worth $430,475, According to a Recent SEC Filing